1-Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. The lancet. 2010;375(9730):1969-87.
2-Van Der Ark AA, Hozbor DF, Boog CJ, Metz B, Van Den Dobbelsteen GP, Van Els CA. Resurgence of pertussis calls for re-evaluation of pertussis animal models. Expert review of vaccines. 2012;11(9):1121-37
3-National Institue of Public Healt and The Environment, Vaccine Technology Transfer centre. DTP Vaccine Production, 1998.Bilthoven: Netherland; 1998. P. 151-161
4-Carbonetti NH, Artamonova GV, Van Rooijen N, Ayala VI. Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infection and immunity. 2007;75(4):1713-20
5-WHO (2005a). Generic protocol for estimating the burden of pertussis in young children. Retrieved 16 April, 2008, from http://whqlibdoc.who.int/hq/2005/WHO_IVB_05.15.p df.
6-Westdijk J, van den Ijssel J, Thalen M, Beuvery C, Jiskoot W. Quantification of cell-associated and free antigens in Bordetella pertussis suspensions by antigen binding ELISA. Journal of Immunoassay and Immunochemistry. 1997;18(3):267-84.
7-Ferencik M. "Hand book of Immunochemistry" SE1 8HN, Chapman and Hall, London 1993, p 310-363.
8-Jadhav S, Gairola S. Composition of acellular pertussis and combination vaccines: a general review. Biologicals. 1999;27(2):105-10.
9-Ibsen PH, Petersen JW, Heron I. Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine. Vaccine. 1993;11(3):318-22.
10-WHO, Manual for quality Control of Diphtheria, Tetanus and Pertussis vaccines,WHO/IVB/11.11, 2013 April, 175-190